Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

Seeking investors

Biotec Pharmacon

Biotec Pharmacon is a biopharmaceutical company that develops and manufactures new immunomodulatory products and cold adapted marine enzymes. The company focuses on new and effective solutions within wound care, cancer therapies and other immune related disease areas, and aspires to become a leading supplier of novel enzymes for diagnostics and genetic research.

Read more

Chundsell Medicals

Annual & quarterly reports
More reports

Chundsell Medicals seeks 20.0 MSEK at a pre‐money valuation of 89.7 MSEK, entailing 18.2% ownership and 16.5% ownership fully diluted. The proceeds are intended to support and accelerate our commercialisation process.

Read more

Serodus

Serodus ASA is a Scandinavian drug development company, focusing on new therapeutic products for the treatment of diabetes and diabetic comorbidities with large unmet clinical needs.Serodus strives to increase shareholders value through advancing its portfolio to value-creating clinical milestones. With the current drug candidates supported by exceptional competencies to develop them, Serodus is uniquely positioned for success

Read more
More investment opportunities

Partnership opportunities

No items found.
More partnership opportunities

Investors

No items found.

Sunstone

Headquartered in Copenhagen, Sunstone Capital is an early-stage Life Science and Technology venture capital company investing in European start-up companies with strong potential to achieve global success in their markets. Since our establishment in 2007, we have built a strong portfolio currently totaling 50 companies and have completed several successful trade sales and IPOs.

Read more

Beacon Angels

Founded 2/2006, Beacon Angels, a Boston-based angel group, celebrated a significant exit in the sale of SmartCells to Merck in December 2010.

Read more
More investors